ASML price target lowered to $1,148 from $1,207 at JPMorgan

JPMorgan lowered the firm’s price target on ASML to $1,148 from $1,207 and keeps an Overweight rating on the shares. The firm says the company’s 2025 sales outlook “is doable” after the guidance reduction. It updated AMSL’s model to incorporate the Q3 results and revised company outlook and says that barring any new government intervention on China shipments, the market can look forward to a better 2026.